Sildenafil Tablet
Product Images NDC 68071-2537

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68071-2537). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2537 9)

Sildenafil 20 mg tablets label from NuCare Pharmaceuticals, Inc. The label shows the proprietary name Sildenafil, strength 20 mg, oral tablet dosage form, and a package size of 90 tablets. It includes manufacturer details for Ajanta Pharma Limited, Mumbai, India, and storage instructions to keep at controlled temperatures of 68-77°F. The label also contains barcodes, lot, expiration, and serial number placeholders.*

FDA Label Image

Figure1 (Sildenafil Figure 1)

A line graph depicting the estimated cumulative mortality rate (%) over a 5-year period for three groups categorized by dose level: High Dose, Medium Dose, and Low Dose. The graph plots time in years on the x-axis against mortality rate on the y-axis, with the number at risk for each group listed above the graph at multiple time points.*

FDA Label Image

Sildenafil_fig2 (Sildenafil Figure 2)

A chart showing the relative fold change and 90% confidence interval for sildenafil's pharmacokinetics (AUC and Cmax) when taken with various interacting drugs. The chart includes a recommendation column indicating if dose adjustment or coadministration is advised for each interacting drug.*

FDA Label Image

Figure3 (Sildenafil Figure 3)

A chart showing fold changes and 90% confidence intervals for interacting drugs with Sildenafil. It compares parameters such as AUC and Cmax for various drugs, listing recommendations related to dose adjustment, with most drugs requiring no dose adjustment except Ritonavir, which is noted as coadministration not recommended.*

FDA Label Image

Figure4 (Sildenafil Figure 4)

A scatter plot graph depicting change from baseline in meters on the vertical axis, measured across study weeks 4, 8, and 12 on the horizontal axis. Data points represent arms for Placebo, Sildenafil 40 mg TID, Sildenafil 80 mg TID, and Sildenafil 20 mg TID treatments, with error bars indicating variability at each time point.*

FDA Label Image

Figure5 (Sildenafil Figure 5)

A forest plot depicting placebo-corrected changes in 6-minute walk distance for Sildenafil 20 mg taken three times daily. The plot shows subgroup analyses based on baseline walk distance, etiology, pulmonary hypertension criteria, gender, age, mean pulmonary artery pressure (PAP), and pulmonary vascular resistance index (PVRI). Each subgroup comparison includes mean values with error bars representing confidence intervals.*

FDA Label Image

Figure6 (Sildenafil Figure 6)

A line graph depicting the percentage of patients without a clinically worsening event over time from randomization (days 0 to 112). Two groups are compared: one treated with Sildenafil (dashed line) and one with placebo (solid line). The graph shows a higher percentage of patients without worsening in the Sildenafil group throughout the study period.*

FDA Label Image

Sildenafil-figure-7 (Sildenafil Figure 7)

A line plot graph showing the mean change from baseline in meters over 12 weeks of study for Sildenafil at three dosages: 1 mg TID, 5 mg TID, and 20 mg TID. The graph includes error bars representing the standard error for each dosage at weeks 4, 8, and 12. The x-axis represents the study weeks, and the y-axis shows the change from baseline in meters.*

FDA Label Image

Structure (Sildenafil Structure)

Chemical structure of Sildenafil, showing its molecular arrangement with labeled functional groups and ring systems as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.